Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory regulatory alert

Kenya PPB warns on fake Postinor-2

Analysis based on 9 articles · First reported Aug 13, 2026 · Last updated Aug 14, 2026

Sentiment
-30
Attention
2
Articles
9
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The alert may temporarily reduce consumer trust in emergency contraceptives in Kenya, potentially affecting sales of Postinor-2 and similar products. Gedeon Richter, the legitimate manufacturer, faces reputational risk and potential revenue impact from counterfeit competition, though the company is not implicated in wrongdoing.

Pharmaceuticals Healthcare

The Kenya — Pharmacy and Poisons Board (PPB) of Kenya issued a public alert warning about a falsified batch of Postinor-2 emergency contraceptive pills (levonorgestrel 0.75 mg, batch T34197R) circulating in the Kenyan market. The counterfeit product falsely claims to be manufactured by Gedeon Richter. PPB identified multiple differences from genuine packs, including batch printing, patient information leaflet errors, carton sealing, color intensity, and authentication logo font. The regulator warned that the fake pills may contain incorrect active ingredient amounts, no active ingredient, harmful contaminants, or undeclared substances, posing health risks. PPB advised healthcare professionals to verify stock authenticity and quarantine suspected products, and urged the public and supply chain actors to report encounters. Investigations led to the arrest of two individuals in possession of the falsified product. PPB also reminded suppliers to procure only from licensed sources, citing the Pharmacy and Poisons Act. Tharaka Nithi Governor Muthomi Njuki separately expressed concern about fake P2 pills and falsified HIV testing kits.

80 Kenya — Pharmacy and Poisons Board flagged falsified batch
60 Kenya — Pharmacy and Poisons Board arrested two individuals
30 Muthomi Njuki raised concerns
govactor
The regulator issued the alert, conducted the analysis, and is leading investigations, including arrests. Its actions reinforce its role in safeguarding public health.
Importance 100.0 Sentiment 20.0
stock
The company's product is counterfeited, causing potential reputational and financial harm, though it is not at fault. It cooperates with regulators to distinguish genuine products.
Importance 80.0 Sentiment -20.0
cnt
The country faces public health risks from counterfeit contraceptives and broader counterfeit medicine issues, prompting regulatory action and public concern.
Importance 70.0 Sentiment -30.0
per
As PPB CEO, he authored the public alert and is the public face of the regulatory response, enhancing his profile as a health regulator.
Importance 60.0 Sentiment 10.0
per
The governor raised public concerns about fake P2 pills and HIV testing kits, adding political attention to the counterfeit medicine problem.
Importance 30.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.